Key result
Drug-eluting balloons offer a promising alternative to stent-based percutaneous coronary intervention, particularly for small vessel disease and in-stent restenosis, though head-to-head data remains limited.
Why the study?
Stent-based revascularization has undesirable long-term effects, higher costs, and more complex regimens compared to balloons, prompting interest in drug-eluting balloons.
Does drug-eluting balloon improve clinical outcomes and reduce complications compared to stent-based intervention in patients with coronary artery disease?
Does drug-eluting balloon improve clinical outcomes and reduce complications compared to stent-based intervention in patients with coronary artery disease?
Answers are grounded in this paper and cite their sources.
Drug-eluting balloons may offer clinical and safety benefits over traditional stent-based interventions in specific percutaneous coronary intervention scenarios.
BACKGROUND: Coronary artery disease is one of the major issues in the medical world around the globe. The prevalence tends to increase. The use of coronary intervention is one of the ways often used in the management of coronary artery disease due to its satisfying result from earlier studies. Nowadays, there are several different techniques in coronary intervention: balloon vs stent. MAIN BODY: The stent-based vascular interventions are increasingly being used over balloon-based coronary intervention. However, revascularization intervention using stent often have undesirable long-term effects compared to balloon. Besides, stent-based interventions are also considered more expensive, use more complicated techniques, and use more drug regimens. On the other hand, percutaneous coronary intervention techniques using balloons coated by anti-proliferation drugs have begun to be glimpsed by many interventionists. Studies have found many benefits that cannot be given by stent-based intervention therapy. CONCLUSIONS: Angioplasty using percutaneous coronary intervention techniques reveals satisfying result compared to conservative medical treatment. The indication and technique of percutaneous coronary intervention is still evolving until now. Currently, percutaneous coronary intervention using stent, either bare-metal stent or drug-eluting stent, is preferred by interventionist. Nevertheless, recent clinical trial favors the using of drug-eluting balloon for percutaneous coronary intervention in terms of both clinical outcome and complication in several scenarios.
No takes yet. Share an insight, caveat, or question.
Laksono et al. (2020) conducted a review in Coronary artery disease. Drug-eluting balloon vs. Stent-based percutaneous coronary intervention was evaluated. Drug-eluting balloons offer a promising alternative to stent-based percutaneous coronary intervention, particularly for small vessel disease and in-stent restenosis, though head-to-head data remains limited.
Synapse has enriched 10 related papers. Consider them for comparative context: